查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387490

螢光原位雜合技術 (FISH) 市場報告：2030 年趨勢、預測與競爭分析

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

螢光原位雜合技術 (FISH) 趨勢和預測

到 2030 年，全球螢光原位雜合技術 (FISH) 市場預計將達到 18.4 億美元，2024 年至 2030 年年複合成長率為 7.6%。該市場的主要促進因素是癌症和遺傳疾病患者數量的增加以及 FISH 產品的持續進步。全球螢光原位雜合技術 (FISH) 市場的未來前景廣闊，在癌症研究、基因研究、感染疾病和個人化醫療市場中充滿機會。

螢光原位雜合技術 (FISH) 市場洞察

Lucintel 預測，在預測期內，消耗品仍將是最大的細分市場。

在這個市場中，由於癌症盛行率的增加和政府對癌症研究的支持不斷增加，預計癌症研究將出現最高的成長。

由於乳癌和感染疾病治療研發投資的增加，預計北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球螢光原位雜合技術（FISH）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球螢光原位雜合技術 (FISH) 市場趨勢 (2018-2023) 和預測 (2024-2030)
  • 按產品類型分類的全球螢光原位雜合技術 (FISH) 市場
    • 消耗品
    • 裝置
    • 軟體
  • 按技術分類的全球螢光原位雜合技術 (FISH) 市場
    • DNA螢光原位雜合技術
    • RNA螢光原位雜合技術
    • PNA螢光原位雜合技術
    • 其他
  • 全球螢光原位雜合技術 (FISH) 市場（按應用）
    • 癌症研究
    • 基因研究
    • 感染疾病
    • 個人化醫療
    • 其他
  • 以最終用途分類的全球螢光原位雜合技術 (FISH) 市場
    • 醫院和診所
    • 診斷實驗室
    • 製藥和生物技術公司
    • 受託研究機構
    • 學術研究所
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球螢光原位雜合技術 (FISH) 市場（按地區）
  • 北美螢光原位雜合技術（FISH）市場
  • 歐洲螢光原位雜合技術（FISH）市場
  • 亞太地區螢光原位雜合技術 (FISH) 市場
  • 其他地區螢光原位雜合技術（FISH）市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球螢光原位雜合技術 (FISH) 市場成長機會
    • 全球螢光原位雜合技術 (FISH) 市場成長機會（按技術）
    • 全球螢光原位雜合技術 (FISH) 市場成長機會（按應用）
    • 全球螢光原位雜合技術 (FISH) 市場成長機會（按最終用途）
    • 全球螢光原位雜合技術 (FISH) 市場成長機會（按地區）
  • 全球螢光原位雜合技術 (FISH) 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球螢光原位雜合技術 (FISH) 市場產能擴張
    • 全球螢光原位雜合技術 (FISH) 市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific
簡介目錄

Fluorescent in Situ Hybridization (FISH) Trends and Forecast

The future of the global fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets. The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

A more than 150-page report is developed to help in your business decisions.

Fluorescent in Situ Hybridization (FISH) by Segment

The study includes a forecast for the global fluorescent in situ hybridization (FISH) by product type, technology, application, end use, and region.

Fluorescent in Situ Hybridization (FISH) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instrument
  • Software

Fluorescent in Situ Hybridization (FISH) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • DNA Fluorescent in Situ Hybridization
  • RNA Fluorescent in Situ Hybridization
  • PNA Fluorescent in Situ Hybridization
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer Research
  • Genetic Research
  • Infectious Disease
  • Personalized Medicine
  • Others

Fluorescent in Situ Hybridization (FISH) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmaceuticals & Biotechnology Companies
  • Contract Research Organisations
  • Academic & Research Organisations
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Fluorescent in Situ Hybridization (FISH) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fluorescent in situ hybridization (FISH) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fluorescent in situ hybridization (FISH) companies profiled in this report include-

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Fluorescent in Situ Hybridization (FISH) Market Insights

Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Within this market, cancer research is expected to witness the highest growth due to increasing prevalence of cancer and rising government support for cancer research.

North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Features of the Global Fluorescent in Situ Hybridization (FISH) Market

Market Size Estimates: Fluorescent in situ hybridization (FISH) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fluorescent in situ hybridization (FISH) market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Fluorescent in situ hybridization (FISH) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the fluorescent in situ hybridization (FISH) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fluorescent in situ hybridization (FISH) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the fluorescent in situ hybridization (FISH) market size?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030.

Q2. What is the growth forecast for fluorescent in situ hybridization (FISH) market?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the fluorescent in situ hybridization (FISH) market?

Answer: The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

Q4. What are the major segments for fluorescent in situ hybridization (FISH) market?

Answer: The future of the fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets.

Q5. Who are the key fluorescent in situ hybridization (FISH) market companies?

Answer: Some of the key fluorescent in situ hybridization (FISH) companies are as follows:

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Q6. Which fluorescent in situ hybridization (FISH) market segment will be the largest in future?

Answer: Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Q7. In fluorescent in situ hybridization (FISH) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the fluorescent in situ hybridization (FISH) market by product type (consumables, instrument, and software), technology (DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others), application (cancer research, genetic research, infectious disease, personalized medicine, and others), end use (hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organisations, academic & research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fluorescent in Situ Hybridization (FISH) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Fluorescent in Situ Hybridization (FISH) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instrument
    • 3.3.3: Software
  • 3.4: Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 3.4.1: DNA Fluorescent in Situ Hybridization
    • 3.4.2: RNA Fluorescent in Situ Hybridization
    • 3.4.3: PNA Fluorescent in Situ Hybridization
    • 3.4.4: Others
  • 3.5: Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 3.5.1: Cancer Research
    • 3.5.2: Genetic Research
    • 3.5.3: Infectious Disease
    • 3.5.4: Personalized Medicine
    • 3.5.5: Others
  • 3.6: Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Diagnostic Laboratories
    • 3.6.3: Pharmaceuticals & Biotechnology Companies
    • 3.6.4: Contract Research Organisations
    • 3.6.5: Academic & Research Organisations
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 4.2: North American Fluorescent in Situ Hybridization (FISH) Market
    • 4.2.2: North American Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.3: European Fluorescent in Situ Hybridization (FISH) Market
    • 4.3.1: European Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.3.2: European Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.4: APAC Fluorescent in Situ Hybridization (FISH) Market
    • 4.4.1: APAC Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.4.2: APAC Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.5: ROW Fluorescent in Situ Hybridization (FISH) Market
    • 4.5.1: ROW Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.5.2: ROW Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 6.1.3: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 6.1.4: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 6.1.5: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 6.2: Emerging Trends in the Global Fluorescent in Situ Hybridization (FISH) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abnova Corporation
  • 7.2: Agilent Technologies
  • 7.3: Biocare Medical
  • 7.4: Biodot
  • 7.5: F. Hoffmann-LA Roche
  • 7.6: Genemed Technologies
  • 7.7: Merck
  • 7.8: PERKINELMER
  • 7.9: Qiagen
  • 7.10: Thermo Fisher Scientific